US antitrust spotlight on the pharmaceutical industry
Companies seeking mergers can expect scrutiny and litigation
Insight
US antitrust spotlight on the technology industry
Is 2021 a year of change?
Insight
US antitrust policy: Revolution or evolution?
Businesses with high market shares may find themselves under the microscope
Alert
The Anti-Money Laundering Act of 2020—Expanding Anti-Money Laundering Reporting Responsibilities to Small Businesses
Alert
The European Court of Justice affirms the right to silence
Alert
Grants of early termination of HSR waiting period temporarily suspended by DOJ and FTC – merging parties should expect to wait the full 30 days until further announcement
Alert
FTC Announces Annual Changes to HSR Thresholds (2021)
HSR Thresholds Decline for the First Time Since 2010
